Could a common diabetes drug help seniors with COPD?
NCT ID NCT07275359
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looks at whether metformin, a drug used for diabetes, is safe and tolerable for older adults (65+) with COPD who do not have diabetes. Researchers will also check if metformin changes blood markers linked to aging. The goal is to see if this approach is feasible for a larger future study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke Asthma, Allergy, and Airway Center
Durham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New inhaled compound aims to ease COPD breathing woes
- Ultrasound might reveal hidden lung damage in COPD
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- Can a gentle nasal breeze unclog the Lungs' smallest airways?
- Can Home-Based lung rehab win over more COPD patients?
- Breathing battle: can simple exercises ease COPD symptoms?